According to the reporter, during laparoscopic oophorectomy, the forceps were difficult to pass through the port, the tip of blunt dilator was found to be chipped in the camera image and damage was noticed.When searched for the fragment of the chipped part, it was stuck into the dermis of the port incision.The surgeon felt resistance when inserting the trocar.The trocar was pulled out and the chipped part was retrieved with forceps under direct view.A new product was taken out and the procedure was completed successfully.The surgical time was extended by less than 30 minutes.There was no patient injury.
|
Evaluation summary: medtronic conducted an investigation based upon all information received.The device was available for evaluation.Visual inspection noted that the circular seal and trocar appeared intact.The distal end of the cannula was gouged with a piece missing.Functionally, the device passed an air leak test.The cannula tip was checked and pin gauge was within specification.No resistance was noted during testing by inserting and removing the device into the cannula.It was reported that the user experienced difficulty in the insertion or removal of the device to or from the port, there was difficulty removing the device from the patient, and the device broke.The reported issues could not be confirmed.The most likely cause could not be established from the information available.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all medtronic quality specifications.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|